Laboratorios Richmond SACIF

Laboratorios Richmond SACIF Current Assets

The Current Assets of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 68.62 B ARS. In the previous year, Current Assets was 31.40 B ARS — a change of 118.54% (higher).

Current Assets

68.62 BARS

YoY

118.54%

Last updated:

Current Assets of Laboratorios Richmond SACIF is 2024 68.62 B ARS. Current Assets of Laboratorios Richmond SACIF was 2023 31.40 B ARS. It decreases by 118.54% higher compared to the previous year.

The Laboratorios Richmond SACIF Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
2.03 B ARS
Jan 1, 2018
3.03 B ARS
Jan 1, 2019
4.48 B ARS
Jan 1, 2020
8.16 B ARS
Jan 1, 2021
30.07 B ARS
Jan 1, 2022
14.04 B ARS
Jan 1, 2023
31.40 B ARS
Jan 1, 2024
68.62 B ARS
The Laboratorios Richmond SACIF Current Assets history
YEARCurrent AssetsYoY
68.62 BARS+118.54%
31.40 BARS+123.63%
14.04 BARS-53.30%
30.07 BARS+268.43%
8.16 BARS+82.32%
4.48 BARS+47.90%
3.03 BARS+48.84%
2.03 BARS+179.83%
726.58 MARS+68.74%
430.60 MARS+46.81%
293.30 MARS+49.11%
196.70 MARS+21.72%
161.60 MARS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Current Assets of Laboratorios Richmond SACIF is 68.62 B ARS in 2024.

Current Assets of Laboratorios Richmond SACIF changed from 31.40 B ARS to 68.62 B ARS, representing a 118.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's ARS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Laboratorios Richmond SACIF historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF